Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2005
11/30/2005EP1432708B1 Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity
11/30/2005EP1401839B9 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene
11/30/2005EP1392337B1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
11/30/2005EP1317483B1 Variants of allergenic proteins of the group 2 of dermatophagoides
11/30/2005EP1289534B1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/30/2005EP1221941A4 Powder pharmaceutical formulations
11/30/2005EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/30/2005EP1144372B1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
11/30/2005EP1109909B1 Grf analogs with increased biological potency
11/30/2005EP0808364B1 Human pancreatic cell lines: developments and uses
11/30/2005CN1703425A Crystallization of IGF-1
11/30/2005CN1703424A GLP-1 derivatives and transmicosal absorption preparations thereof
11/30/2005CN1703406A Chirale oxazole-arylpropionic acid derivatives and their use as PPAR agonists
11/30/2005CN1703405A Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1703245A Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity
11/30/2005CN1703244A Association between a PPAR ligand and an antioxidant agent and use thereof for treating obesity
11/30/2005CN1703232A Method of treating diabetes using plant argyrolobium roseum extract
11/30/2005CN1703215A Stabilized pharmaceutical preparation comprising an amorphous active substance
11/30/2005CN1703197A Injectable depot compositions and uses thereof
11/30/2005CN1702070A N-benzyl acryloyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1702069A Alpha-piperazine substituted phenyl-propionic acid derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1702068A Alkanoyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1229390C Peptides that lower blood glucose levels
11/30/2005CN1229388C N-terminal modified protein compositions and methods therefor
11/30/2005CN1229381C Macrolides compound
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/30/2005CN1229362C Bicyclic guanidine derivatives and therapeutic uses thereof
11/30/2005CN1229345C N-(indolcarbonyl) piperazin derivatives
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229335C Nervinolin derivatives
11/30/2005CN1229334C Inhibitors of alpha4 mediated cell adhesion
11/30/2005CN1229331C Inhibitor of monoamine uptake
11/30/2005CN1229315C Method of converting inositol derivative in bitter buckwheat seed into its monomer and its extraction product
11/30/2005CN1229128C Detoxification tea of white bamboo
11/30/2005CN1229113C A Pharmaceutical composition for the treatment of autoimmune diseases
11/30/2005CN1229032C Process and production for promoting weight loss for overweight dogs
11/29/2005US6969729 An indole or benz(g)indole-2,3-dione-3-oxime compounds; therapeutic treatment of respiratory disorders, urogenital disorders, cardiovascular disorders, brain and psychological disorders, gastrointestinal disorders
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969725 Oxazole derivatives
11/29/2005US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
11/29/2005US6969720 2,6,9-trisubstituted purine derivatives which are inhibitors of cyclin/cdk (cyclin dependent kinases) complexes
11/29/2005US6969719 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
11/29/2005US6969717 Azaindole kinase inhibitors
11/29/2005US6969712 Alzheimer's disease; central nervous system disorders; antidepressants; antidiabetic agents; analgesics
11/29/2005US6969710 Compounds
11/29/2005CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
11/29/2005CA2123048C Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments
11/24/2005WO2005110989A1 Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
11/24/2005WO2005110980A2 Aryl sulfones and uses related thereto
11/24/2005WO2005110454A2 Protective binding members of pyy for the treatment of metabolic disorders
11/24/2005WO2005110400A1 Lipase inhibitor, cholesterol esterase inhibtor, neutral fat absorption inhibitor, cholesterol absorption inhibitor and cholesterol ester absorption inhibitor
11/24/2005WO2005110394A1 Therapeutic agent for diabetes
11/24/2005US20050261502 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
11/24/2005US20050261501 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261378 Process for decreasing adiposity using vitamin A as a dietary supplement
11/24/2005US20050261373 Prostaglandin compounds for the treatment of obesity
11/24/2005US20050261361 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
11/24/2005US20050261360 Dissolving the crystalline form in acetone, allowing to convert to amorphous form and then precipitating it out
11/24/2005US20050261359 Novel processes for preparing amorphous atorvastatin hemi-calcium
11/24/2005US20050261349 Medicine for prevention or treatment of diabetes
11/24/2005US20050261338 Beta2-adrenergic receptor agonists
11/24/2005US20050261319 Novel 2-amino-4-quinazolinones and 2-amino-4-oxoquinazolones as LXR nuclear receptor binding compounds with partial agonistic properties
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261281 Pharmaceutical compounds
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005US20050261271 Dipeptidyl peptidase inhibitors
11/24/2005US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
11/24/2005US20050261259 Phytosterol and/or phytostanol derivatives
11/24/2005US20050261256 Treatment of ICU-associated hypocalcemia with vitamin D compounds
11/24/2005US20050261248 New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives
11/24/2005US20050261206 chemical intermediates to derivatives such as 3-(beta -D-Glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole; treatment of diabetes or obesity; inhibit SGLT2 (Na+/glucose cotransporter 2)
11/24/2005US20050261205 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
11/24/2005US20050261199 Amidated D-Proline, D-Tyrosine, D-Valine, and D-Leucine, D-Threonine, D-Valline; lowering serum triglyceride levels
11/24/2005US20050261198 sulfur-containing proanthocyanidin oligomer having a low molecular weight, made by reacting a precursor with a mercapto compound has improved bioavailability; antioxidant; derived from buckwheat
11/24/2005US20050261192 Novel polypeptide and its DNA
11/24/2005US20050260767 Treatment with cytokines
11/24/2005US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators
11/24/2005US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof
11/24/2005US20050260282 Novel hypoglycemic agent, diabetes preventive agent, deep sea water concentrate, and method for producing deep sea water concentrate
11/24/2005US20050260228 Vaccines absorbable by the transmucosal way
11/24/2005US20050260185 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase
11/24/2005US20050260174 Systems and methods for treating patients with processed lipoaspirate cells
11/24/2005US20050260145 Oil soluble compositions
11/24/2005CA2567166A1 Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
11/24/2005CA2566703A1 Methods of inhibiting proinflammatory cytokine expression using ghrelin
11/24/2005CA2565154A1 Compositions for affecting weight loss
11/24/2005CA2563793A1 Polymorphic forms of nateglinide
11/24/2005CA2561525A1 Aryl sulfones and uses related thereto
11/24/2005CA2507712A1 Pharmaceutical compounds
11/24/2005CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators
11/23/2005EP1598422A2 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
11/23/2005EP1598369A1 Antibody and use thereof
11/23/2005EP1598350A1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis
1 ... 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 ... 1298